UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000047367
Receipt No. R000054025
Scientific Title Cyber knife as a treatment for malignant tumors: prospective observational study
Date of disclosure of the study information 2022/05/01
Last modified on 2022/04/02 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Cyber knife as a treatment for malignant tumors: prospective observational study
Acronym CK study
Scientific Title Cyber knife as a treatment for malignant tumors: prospective observational study
Scientific Title:Acronym CK study
Region
Japan

Condition
Condition lung cancer, hepatoma, renal cancer, spinal cord tumor, and metastasis
Classification by specialty
Medicine in general Radiology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To elucidate the efficacy of cyber knife for malignant tumor.
Basic objectives2 Others
Basic objectives -Others Local control rate.
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Over all survival
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Historical
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Device,equipment Maneuver
Interventions/Control_1 5 fraction 35 to 45 Gy.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Diameter equal to 5 cm or less than 5cm, primary lung cancer, renal cancer or hepatoma, tumor numbers equal to 3 or less than 3 metastatic lung tumor or liver tumor. Local prostate cancer or pancreas cancer. Metastasis equal to 5 or less than 5. No organs failure. Informed consent.
Key exclusion criteria Sever organs failure. Presence of dementia.
Target sample size 500

Research contact person
Name of lead principal investigator
1st name Takamasa
Middle name
Last name Ohki
Organization Shioda Memorial Hospital
Division name Cyber knife center
Zip code 297-0203
Address kori 550-1 Nagaramachi Choseigun Chiba
TEL 0475-35-0099
Email anb72547@nifty.com

Public contact
Name of contact person
1st name Takamasa
Middle name
Last name Ohki
Organization Shioda Memorial Hospital
Division name Cyber knife center
Zip code 297-0203
Address kori 550-1 Nagaramachi Choseigun Chiba
TEL 0475-35-0099
Homepage URL
Email anb72547@nifty.com

Sponsor
Institute Shioda Memorial Hospital
Institute
Department

Funding Source
Organization Shioda Memorial Hospital
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Shioda Memorial Hospital
Address kori 550-1 Nagaramachi Choseigun Chiba
Tel 0475-35-0099
Email anb72547@nifty.com

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2022 Year 05 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2022 Year 04 Month 01 Day
Date of IRB
Anticipated trial start date
2022 Year 05 Month 01 Day
Last follow-up date
2032 Year 04 Month 30 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2022 Year 04 Month 02 Day
Last modified on
2022 Year 04 Month 02 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054025